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Abstract
Background: We explored survival of skin cancer and its determinants in Kurdistan province of
Iran.
Methods: In a retrospective cohort design, we identified all registered skin cancer patients in Kur-
distan Cancer Registry from year 2000 to 2009. Information on time and cause of death were ob-
tained from Registrar’s office and information on type, stage and anatomic locations were extracted
from patients’ hospital records. Additional demographic information was collected via a telephone
interview. We calculated the 3 and 5 years survival. Survival experiences in different groups were
compared using log rank test. Cox proportional hazard model was built and hazard ratios and their
95% confidence intervals were calculated.
Results: Of a total of 1353, contact information for 667 patients were available, all of which were
followed up. 472 telephone interviews were conducted. Mean follow-up time was 34 months. We
identified 78 deaths in this group of patients and 44 of them were because of skin cancer. After con-
trolling for confounding, tumour type, anatomical location, and diseases stage remained significantly
associated with survival. Hazard ratios for death because of squamous cell carcinoma was 74.5
(95%CI: 4.8-1146) and for melanoma was 24.4 (95%CI: 1.3-485) compared with basal cell carcino-
mas.  Hazard ratio for tumours in stage 4 was 16.7 (95%CI: 1.8-156.6) and for stage 3 was 16.8
(95%CI: 1.07-260) compared with stage 1 and 2.
Conclusion: Tumour stage is independently associated with survival. Relatively low survival rates
suggest delayed diagnosis. Increasing public awareness through media about the warning signs of
skin cancers could increase the chance of survival in these patients.
Keywords: Skin cancer, Survival analysis, Kaplan Meier, Cox model.
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Introduction
Prevalence of skin cancer has increased in
recent decades and its public health burden
has also grown alongside (1,2). Although
mortality rate from skin cancer is relatively
low, it can cause a great deal of morbidity
instead, emphasising its public health im-
portance (3). It has been suggested there-
fore that skin cancer will play an important
part in the global burden of disease in the
next decade (4).
There are three major types of skin cancer
(2,3). Basal cell carcinoma is the most
common type of skin cancer. Squamous
cell carcinoma is in the second place. It is
less prevalent than the basal cell type but it
can cause more tissue damage as the tu-
mour usually invades the adjacent tissue
and therefore is more aggressive (3). Ma-
lignant melanoma is the third common skin
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cancer type. It was once very rare about 50
years ago but its prevalence has since in-
creased considerably (3). Although it only
comprises 3% of all skin cancer types, it is
still responsible for 75% of deaths due to
skin cancer (5).
Skin cancer is an important health prob-
lem in Iran. According to Iranian National
Cancer Registry 2003-2007 reports it is the
most common cancer type in men. In wom-
en it is the second most prevalent type of
all cancers. When we put data for men and
women together it still holds the first place
among the most common cancer types in
Iranian population (6-13).
Estimating survival rate and factors asso-
ciated with it is an important first step in
any effective program aimed at decreasing
the overall burden of any type of cancer.
Knowledge of 3 or 5 years survival rates
could also help in provision of healthcare in
these patients as understandably they will
have particular needs during this period.
We have therefore studied survival rates of
skin cancer in Kurdistan province of Iran
and its associated factors using data from
Kurdistan cancer Registry.
Methods
In this retrospective cohort study that was
conducted in 2010 we identified all patients
registered with Kurdistan Cancer Registry
as having any type of skin cancer between
years 2000 and 2009 and extracted all their
demographic and tumour related infor-
mation. We then contacted all those who
had a telephone number recorded in their
files and willing to participate that com-
prised about half of the registered skin can-
cer population and entered them into the
study. Characteristics of study subjects
were compared with the rest of the regis-
tered skin cancers. Through linkage with
Registrar’s provincial office information on
date and cause of death for study subjects
were obtained and their vital status double
checked when contacted. A telephone in-
terview was carried out with the patient if
s/he was alive or with a close relative in
case the patient had passed away. Those we
could not reach at our first try were con-
tacted twice more at different times.
We used a two-part questionnaire for our
data collection. The first part was complet-
ed using the available data at the cancer
registry. The second part was filled during
the telephone interview with the patients or
their first degree relatives.
In addition to their vital status, questions
were asked about a list of factors that are
potentially associated with survival. These
factors included age, sex, tumour type, ana-
tomic location of the tumour, place of resi-
dence, any report of delay in diagnosis of
cancer, tumour stage, and educational level
of the patients. Delay in diagnosis was de-
fined as the time between first appearance
of symptoms and the definitive diagnosis of
skin cancer. Anatomical locations of the
tumours were categorised according to the
Iranian National Registry guidelines.
Tumour stage was determined using the
TNM system (according to the seventh edi-
tion of the American Joint Committee on
Cancer (AJCC). AJCC-7 Cancer Staging
Manual includes a major revision of the
staging protocol for cutaneous carcinomas
(14). T stands for tumour and defines the
size of the lesion; N stands for lymph nodes
and describes the degree of involvement of
the adjacent lymph nodes; and M stands for
metastasis and explains whether the tumour
has reached other parts of body. Based on
the above three dimensions tumours are
divided into 5 stages (Table 1). When the
staging information were absent in registry
records, data were collected from hospitals’
files where possible.
We collected data on time and cause of
death from both the relatives and the Kur-
distan Provincial Registrar Office. In case
of any discrepancy between the two, the
family of the patients was contacted direct-
ly in urban areas and indirectly via rural
health center officers (Behvarz) in rural ar-
eas in order to obtain accurate information.
Statistical analysis was conducted using
SPSS 18. Survival analysis methods includ-
ing Kaplan Meier and log rank tests were
used to compare the survival experience in
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different patient categories. Cox propor-
tional hazard regression model was used to
account of the potential confounding varia-
bles. Hazard ratios and their 95% confi-
dence interval were calculated. Proportion-
al hazard assumption was checked for eve-
ry model using log minus log plot.
Results
There were 1353 registered patients of
which, telephone contact details were
available for 667. A total of 472 interviews
were conducted and the remaining 195 pa-
tients could not be reached for a variety of
reasons including change of address (24
cases), wrong number (84 cases), closure of
line (28 cases), and finally 59 cases did not
respond to the calls. Average follow up
time was 34 months. A total of 78 deaths
were detected of which 44 was due to skin
cancer. Study subjects had similar charac-
teristics to the rest of the registered skin
cancers (Table 4).
Of 472 cases that were analysed, 64%
were men and 62% were over 60 years old.
Mean and median ages of the subjects were
64 and 65 years, respectively. According to
tumour histological type, 66% had basal
cell carcinoma, 23% had squamous cell
carcinoma, 3% malignant melanoma, and
the remaining 8% had other types of skin
tumours. 36% of tumours had been diag-
nosed in stage I and II, 15% in stage III and
49% in stage IV (Table 1).
One, two and five years survival rates
were 96%, 91.6, and 85%, respectively.
Table 1. Tumour and patient characteristics by tumour type
Variable BCC SCC MM Other Total
Age(year) N(%) N(%) N(%) N(%) N(%)
<60 128(41.4%) 28(26%) 4(30.8%) 20(46.5%) 180(38%)
60-79 134(43.4%) 59(55%) 7(53.8%) 17(39.5%) 217(46%)
>=80 47(15.2%) 20(18.7%) 2(15.4%) 6(14%) 75(16%)
Total 309(100%) 107(100%) 13(100%) 43(100%) 472(100%)
Sex Male 190(61.5%) 82(76.6%) 6(46.2%) 25(58%) 303(64%)
Female 119(38.5%) 25(23.4%) 7(53.8%) 18(42 %) 169(36%)
total 309(100%) 107(100%) 13(100%) 43(100%) 472(100%)
Place of
residence
Urban 223(72.2%) 61(57%) 12(92.3%) 29(67.5%) 325(69%)
Rural 86(27.8%) 46(43%) 1(7.7%) 14(32.5%) 147(31%)
Total 309(100%) 107(100%) 13(100%) 43(100%) 472(100%)
Tumour
anatomic site
Face 257(83. 5%) 66(62.3%) 3(23%) 16(37%) 342(73%)
scalp and neck 25(8%) 8(7.5%) 1(7.7%) 3(7%) 37(8%)
Trunk 4(1.3%) 3(2.8%) 0 9(21%) 16(3.5%)
Upper extremity
and shoulder
2(0.7%) 6(5.7%) 0 3(7%) 11(2%)
Lower extremity
and hip
0 6(5.7%) 9(69.2%) 8(18.6%) 23(5%)
Multiple sites 2(0. 7%) 5(4.7%) 0 2(4.7%) 9(2%)
Face & scalp
and neck
4(1.3%) 2(1.9%) 0 1(2.3%) 7(1.5%)
External ear 14(4.5%) 10(9.4%) 0 1(2.3%) 25(5%)
Total 308(100%) 106(100%) 13(100%) 43(100%) 470(100%)
Stage StageI & Stage
II
11(64.7%) 5(18.5%) 4(50%) 2(22.2%) 22(36%)
Stage III 4(23.5%) 5(18.5%) 0 0 9(14.8%)
Stage IV 2(11.8%) 17(63%) 4(50%) 7(77.8%) 30(49.2%)
Total 17(100%) 27(100%) 8(100%) 9(100%) 61(100%)
Delay in
diagnosis
(month)
<=24 229(80.4%) 86(89.6%) 12(92.3%) 31(81.6%) 358(83%)
25-48 32(11.2%) 5(5.2%) 1(7.7%) 5(13.2%) 43(10%)
49-72 14(4.9%) 3(3%) 0 0 17(4%)
>=73 10(3.5%) 2(2%) 0 2(5.2%) 14(3%)
Total 285(100%) 96(100%) 13(100%) 38(100%) 432(100%)
Educational
level
Illiterate 189(63.9%) 72(74%) 10(76.9%) 25(62.5%) 296(66.4%)
Below diploma 76(25.7%) 23(23.7%) 2(15.4%) 9(22.5%) 110(24.6%)
=>Diploma 31(10.5%) 2(2%) 1(7.7%) 6(15%) 40(9%)
Total 296(100%) 97(100%) 13(100%) 40(100%) 446(100%)
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There were only 3 cases of deaths in basal
cell carcinoma patients that were attributa-
ble to their skin cancer. Three- year surviv-
al rate for squamous cell carcinoma was
67% and for malignant melanoma 50%.
In univariate analysis age, place of resi-
dence, education, tumour anatomical loca-
tion, type and diseases stage were all signif-
icantly associated with survival. Risk of
death increased with age and was higher in
women than in men but the difference did
not reach statistical significance. People
living in rural areas died twice as faster as
their urban counterparts. Regarding the
anatomical location, facial lesions carried
the lowest risk and involvement of multiple
body site the highest risk of death. Squa-
mous cell carcinoma and malignant mela-
noma patients died 33.6 (95% CI 10.3-
110.6) and 27.2 (95% CI 5.5-135.5) faster
than patients having basal cell carcinomas
that carried the lowest risk. Stage of the
tumour was also significantly associated
with survival. Risk of death increased with
the increase in the tumour stage. Stages I
and II carried the lowest risk. Risk of death
in stage III was 3 (95% CI 0.5-18.6) times
and in stage IV 10.8 (95% CI 2.6-46.2)
times higher compared to the stages I and II
(Table 2).
Cox proportional hazard model was built
to account for the possible confounding ef-
fects of existing variables. The three varia-
bles of tumour type, stage and anatomical
location remained significant in the model
and were independently associated with
survival (Table 3). In model checking, there
was not a serious violation of the propor-
Table 2. Characteristics associated with survival in univariate analysis
Variables No. Event Hazard Ratios and 95% CI
Age (year) 60> 180 7 Reference
60-79 217 23 2.95 (1.3-6.8)
>=80 75 14 6.29 (2.6-15.63)
Total 472 44 Log Rank test, P<0.001
Sex Male 303 29 Reference
Female 169 15 1.03 (0.55-1.9)
Total 472 44 Log Rank test, P=0.07
Place of
residence,
Urban 325 24 Reference
Rural 147 20 2.05 (1.21-3.71)
Total 472 44 Log Rank test, P=0.01
Anatomic site Face 342 24 Reference
Scalp and neck 37 3 1.07 (0.32-3.5)
Trunk 16 1 1.15 (0.15-8.5)
Upper extremity and shoulder 11 1 1.64 (0.22-12)
Lower extremity and hip 23 7 5.27 (2.3-12.3)
Multiple sites 9 4 9.36 (3.3-24.3)
Face & scalp and neck 7 1 1.55 (0.3-11.5)
External ear 25 2 1.1 (0.3-4.7)
Total 470 43 Log Rank test, P<0.001
Type of tumor BCC 309 3 Reference
SCC 107 29 33.66 (10.3-110.6)
MM 13 3 27.2 (5.5-135.5)
Others 43 9 25.8 (7-95.5)
Total 472 44 Log Rank test, P<0.001
Stage Stage I and II 22 2 Reference
Stage III 9 3 3.1 (0.5-18.6)
Stage IV 30 23 10.85 (2.6-46.2)
Total 61 28 Log Rank test, P<0.001
Delay in
diagnosis
(month)
<=24 358 25 Reference
25-48 43 5 1.74 (0.7-4.6)
49-72 17 3 2.4 (0.8-7.9)
>=73 14 2 2 (0.5-7.5)
total 432 35 Log Rank test, P=0.300
Educational
level
illiterate 296 30 Reference
below diploma 110 4 0.33 (0.2-0.9)
=>Diploma 40 1 0.22 (0.03-1.6)
total 446 35 Log Rank test, P=0.02
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tional hazard assumption.
Discussion
We found that the survival figures are rel-
atively low in Kurdistan province com-
pared to similar international studies. One,
two and 5 years survival rates for all skin
cancer were 96%, 91.6% and 85%. In
squamous cell cancer the three-years sur-
vival rate was 67% and the corresponding
figure for malignant melanoma was 50%.
Age, place of residence, education, tumour
anatomical location, type and stage were
associated with survival in univariate anal-
ysis. However after controlling for the pos-
sible confounding factors, type, anatomical
location and stage of the tumour were the
significant predictors of survival.
Our findings regarding the survival rates
for squamous cell carcinoma and malignant
melanoma show that the survival rates in
Kurdistan province is relatively low. In a
prospective study on patients having squa-
mous cell carcinoma in Texas, USA, three
years survival rate was found to be 85%
(15). This figure for most European coun-
Table 3. Variables predicting survival in the final Cox proportional hazard model
Variables subgroups p-value Hazard Ratios 95% confidence interval
Tumor stage stage I and II 0.040 Reference Lower Higher
stage III 0.044 16.8 1.07 260.2
stage IV 0.014 16.7 1.8 156.6
Tumor type Bcc 0.023 Reference
Scc 0.002 74.5 4.8 1146.7
Mm 0.036 24.4 1.3 485
Other 0.013 77 2.5 2412.8
Tumor
Anatomical site
Face 0.170 Reference
scalp and neck 0.033 48.6 1.4 1714.5
Trunk 0.098 0.000 0
Upper extremity and shoulder 0.628 0.6 0.05 6.3
Lower extremity and hip 0.676 0.7 0.2 3.7
Multiple sites 0.437 0.6 0.09 2.8
Face+scalp and neck 0.256 0.2 0.006 3.9
External ear 0.017 0.09 0.011 0.7
Table 4. Comparing some characteristics of interviewed subjects with the rest of the skin cancers registered in Kur-
distan Cancer Registry from year 2000 to 2009
Rest of the registered skin cancers Study subjects
Age N(%) N(%)
below 60 years 295(33.6%) 180 (38%)
60-79 years 482(54.8%) 217 (46%)
80 years and over 102(11.6%) 75(16%)
total 879(100%) 472(100%)
Sex
Male 522(59%) 303(64%)
Female 359(41%) 169(36%)
total 881(100%) 472(100%)
Tumor type
BCC 578(66%) 309(65%)
SCC 220(25%) 107(23%)
MM 21(2%) 13(3%)
Others 62(7%) 43(9%)
total 881(100%) 472(100%)
Anatomical site
Face 612(74%) 342(73%)
Head and neck 81(10%) 37(8%)
Trunk 41(5%) 16(3.5%)
Upper extremities 22(3%) 11(2%)
Lower extremities 37(4%) 23(5%)
Multiple site 0(0%) 9(2%)
Face and neck 4(1%) 7(1.5%)
External ear 27(3%) 25(5%)
total 824(100%) 470(100%)
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tries is around 90% (16). Other reports
from Europe estimates the 5-year survival
rate of melanoma at around 70% (17) and
in the United States the 5-year survival
were  86.8% and 92.0 in men and women
(18). In another review study, survival rates
for malignant melanoma were 78% and
91% in men and women respectively (19).
Our findings, therefore, of a 5 years surviv-
al of 50% for malignant melanoma indicate
a significant gap with the international fig-
ures. A possible explanation for this finding
is the late diagnosis (in stage III or IV) of
the tumour that makes an effective treat-
ment unlikely. Our finding that anatomical
location of the tumour is an independent
predictor of survival is in agreement with
most of the literature on this subject. Stud-
ies from Netherlands (20), California USA
(21), and United States (16) all showed that
anatomical location of tumour is signifi-
cantly associated with survival. Variation in
survival according to the anatomical loca-
tion of the tumour may result from a varia-
tion in tumour invasive behaviour in differ-
ent body sites.
Fig. 1. Kaplan-Meier estimates of disease-specific survival in study cohort by tumour type
Fig. 2. Kaplan-Meier estimates of disease-specific survival in study cohort by tumor stage
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Our study showed that tumour type is an
important predictor of survival (Fig.1). The
difference originates from the tumour inva-
sive behaviour and its ability to send distant
metastasis. In our current study survival
experience of patients with squamous cell
carcinoma were worse than those having
malignant melanoma while in other studies
usually worst survival belongs to malignant
melanoma. In a study from Denmark (22)
and a retrospective cohort analysis (23) in
general, relative survival after basal cell
carcinoma was better than after squamous
cell carcinoma.
In many countries mortality rates for non-
melanoma skin cancer is very low (1). The
possible explanation for our finding is the
late diagnosis of patients having squamous
cell carcinoma. While 50% of melanoma
tumours were in stages I and II at the time
of diagnosis, this figure was 18.5% for
squamous cell carcinoma and the majority
were diagnosed at stages III and IV (Table
1).
Tumour stage is a very important predic-
tor of survival (Fig.2). The higher the stage
of the tumour is at the time of diagnosis,
the lower the survival. Our finding of the
effect of stage on survival was in complete
agreement with the existing literature
(18,20,24).
Age was a significant predictor of surviv-
al in univariate analysis in our study. Simi-
lar findings have been reported by many
researchers (18,20,25), although, some did
not find any association between age, sex
and survival (26). In the current study, men
survived slightly longer than women alt-
hough the association was not significant.
There are other studies that have found
similar results regarding gender, but the
bulk of literature does not support this find-
ing. In these studies, women have a longer
survival than men (18-20,27-30).
Living in a rural area put people in a dis-
advantaged position regarding skin cancer
survival. In the current study 44% of pa-
tients living in the urban areas were diag-
nosed in stage 1 and 2 while the corre-
sponding figure for residents of rural areas
was 27%. Access to the healthcare facilities
and therefore delay in seeking medical at-
tention could explain this difference. Risk
of death was lower in literate people com-
pared with illiterate that could also origi-
nate from delay in asking medical advice.
More than 24 months delay in diagnosis
could double the risk although it did not
reach statistical significance. Delay in di-
agnosis increases the stage of tumour at the
time of diagnosis and therefore could be an
important factor in survival. However we
did not find any association between the
two that might reflect the retrospective de-
sign of this study and subsequent limita-
tions in collecting accurate information on
the actual amount of delay time.
Our study has some strengths and limita-
tions. Accurate recording of time and cause
of death as we had access to registrar office
in Kurdistan province and cross checked
the information in our interviews. On the
other hand, we were unable to ascertain
stage in some patients as we could not ac-
cess all necessary data. Furthermore we
only followed those patients who had their
contact details recorded in their registry
file. This may result in exclusion of some
disadvantaged people from our study.
However, comparison between characteris-
tics of interviewed subjects with the rest of
the skin cancers registered in Kurdistan
Cancer Registry (Table 4) showed no con-
siderable difference between the two popu-
lations. Future studies with a prospective
design could address this limitation and
provide a more accurate estimate of surviv-
al.
Adopting some strategies towards preven-
tion, and timely diagnosis and treatment
could help reduce the burden of the disease
particularly in rural areas. An important
first step is a public education campaign
about causes of skin cancer particularly in
those who are exposed to sun light for long
hours such as farmers. In any educational
campaign in rural areas it is also helpful to
get help from institutions which are not di-
rectly involved in heath matters but are an
important point of access for farmers such
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as those that provide agricultural advice
and equipment. Educating women about
ways of prevention and early signs of skin
cancer is another important step particular-
ly in rural areas. Finally, encouraging fami-
ly physicians for timely referral of patients
to specialist could help with effective
treatment.
In summary our study showed that sur-
vival from skin cancer in Kurdistan prov-
ince is worse than most global figures and
therefore in need of urgent attention. We
found that delay in diagnosis is an im-
portant contributor to this problem. Effec-
tive public health campaign about preven-
tive measures particularly from sun expo-
sure and early signs of disease for timely
diagnosis and treatment could tackle the
problem in long term and increase the sur-
vival indicators in Iranian patients.
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